These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37822560)

  • 1. Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis.
    Kim B; Ko YH; Si J; Na J; Ortore G; Chiellini G; Kim JH
    Comput Struct Biotechnol J; 2023; 21():4717-4728. PubMed ID: 37822560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.
    Bellusci L; Laurino A; Sabatini M; Sestito S; Lenzi P; Raimondi L; Rapposelli S; Biagioni F; Fornai F; Salvetti A; Rossi L; Zucchi R; Chiellini G
    Front Pharmacol; 2017; 8():905. PubMed ID: 29311919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway.
    Rogowski M; Bellusci L; Sabatini M; Rapposelli S; Rahman SM; Chiellini G; Assadi-Porter FM
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
    Rutigliano G; Bandini L; Sestito S; Chiellini G
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Iodothyronamine Decreases Expression of Genes Involved in Iodide Metabolism in Mouse Thyroids and Inhibits Iodide Uptake in PCCL3 Thyrocytes.
    Schanze N; Jacobi SF; Rijntjes E; Mergler S; Del Olmo M; Hoefig CS; Khajavi N; Lehmphul I; Biebermann H; Mittag J; Köhrle J
    Thyroid; 2017 Jan; 27(1):11-22. PubMed ID: 27788620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents Through the Modulation of SIRT6.
    Bellusci L; Runfola M; Carnicelli V; Sestito S; Fulceri F; Santucci F; Lenzi P; Fornai F; Rapposelli S; Origlia N; Zucchi R; Chiellini G
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32110992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells.
    Rogowski M; Gollahon L; Chellini G; Assadi-Porter FM
    FEBS Open Bio; 2017 Apr; 7(4):587-601. PubMed ID: 28396842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on 3-iodothyronamine and its neurological and metabolic actions.
    Zucchi R; Accorroni A; Chiellini G
    Front Physiol; 2014; 5():402. PubMed ID: 25360120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diphenyl-Methane Based Thyromimetic Inhibitors for Transthyretin Amyloidosis.
    Kim B; Ko YH; Runfola M; Rapposelli S; Ortore G; Chiellini G; Kim JH
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases.
    Laurino A; Landucci E; Raimondi L
    Front Endocrinol (Lausanne); 2018; 9():290. PubMed ID: 29928258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of 3-iodothyronamine (3-T
    Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection.
    Laurino A; Gencarelli M; Raimondi L
    Eur J Pharmacol; 2021 Dec; 912():174606. PubMed ID: 34717926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directional thyroid hormone distribution via the blood stream to target sites.
    Janssen ST; Janssen OE
    Mol Cell Endocrinol; 2017 Dec; 458():16-21. PubMed ID: 28257828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation-Prone Structural Ensembles of Transthyretin Collected With Regression Analysis for NMR Chemical Shift.
    Yang W; Kim BS; Muniyappan S; Lee YH; Kim JH; Yu W
    Front Mol Biosci; 2021; 8():766830. PubMed ID: 34746240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine.
    Laurino A; De Siena G; Saba A; Chiellini G; Landucci E; Zucchi R; Raimondi L
    Eur J Pharmacol; 2015 Aug; 761():130-4. PubMed ID: 25941083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?
    Khajavi N; Mergler S; Biebermann H
    Front Endocrinol (Lausanne); 2017; 8():198. PubMed ID: 28861042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM).
    Haiyan Z; Bailong H; Bei Z; Yiming W; Xingde L
    Biomed Res Int; 2020; 2020():1302453. PubMed ID: 32685439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Iodothyronamine and 3,5,3'-triiodo-L-thyronine reduce SIRT1 protein expression in the HepG2 cell line.
    Sacripanti G; Lorenzini L; Bandini L; Frascarelli S; Zucchi R; Ghelardoni S
    Horm Mol Biol Clin Investig; 2020 Mar; 41(1):. PubMed ID: 32114521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution and cardiac metabolism of 3-iodothyronamine.
    Saba A; Chiellini G; Frascarelli S; Marchini M; Ghelardoni S; Raffaelli A; Tonacchera M; Vitti P; Scanlan TS; Zucchi R
    Endocrinology; 2010 Oct; 151(10):5063-73. PubMed ID: 20739399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors.
    Guo X; Liu Z; Zheng Y; Li Y; Li L; Liu H; Chen Z; Wu L
    Drug Des Devel Ther; 2020; 14():1057-1081. PubMed ID: 32210536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.